Active Ingredient History

  • Now
MOVANTIK (naloxegol) is a peripherally-acting mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic noncancer pain. It is being investigated for the treatment of constipation as a side effect of prescription opioid pain medicines.   NCATS

  • Mol. Mass: 651.79
  • ALogP: 1.86
  • ChEMBL Molecules:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$8.7663 - $11.6699
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(5α,6α)-17-allyl-6-[(20-hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl)oxy]-4,5-epoxymorphinan-3,14-diol | az-13337019 oxalate | movantik | moventig | naloxegol | naloxegol oxalate | nktr-118 | nktr-118-oxalate


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue